長期投資家のためのIR情報
バリュートレンド

【8095】アステナホールディングス
医薬品・医薬原料の商社。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.11 2026/07/13 Q2予 68,000 → 0.0% 0.0% 3,400 → 0.0% 0.0% 3,300 → 0.0% 0.0% 2,350 → 0.0% 0.0%
2026.11 2026/04/13 Q1予 68,000 → 0.0% 0.0% 3,400 → 0.0% 0.0% 3,300 → 0.0% 0.0% 2,350 → 0.0% 0.0%
2026.11 2026/01/13 当初予 68,000 - - - 3,400 - - - 3,300 - - - 2,350 - - -
2025.11 2026/01/13 実 62,744 ↓ -2.0% -0.4% 3,017 ↓ -2.7% +50.8% 2,910 ↑ +0.3% +45.5% 2,187 ↑ +21.5% +98.8%
2025.11 2025/10/10 Q3予 64,000 → 0.0% +1.6% 3,100 → 0.0% +55.0% 2,900 → 0.0% +45.0% 1,800 → 0.0% +63.6%
2025.11 2025/07/11 Q2予 64,000 ↑ +1.6% +1.6% 3,100 ↑ +19.2% +55.0% 2,900 ↑ +16.0% +45.0% 1,800 ↑ +20.0% +63.6%
2025.11 2025/05/28 修正予 63,000 → 0.0% 0.0% 2,600 ↑ +30.0% +30.0% 2,500 ↑ +25.0% +25.0% 1,500 ↑ +36.4% +36.4%
2025.11 2025/04/11 Q1予 63,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,100 → 0.0% 0.0%
2025.11 2025/01/14 当初予 63,000 - - - 2,000 - - - 2,000 - - - 1,100 - - -
2024.11 2025/01/14 実 57,993 ↑ +0.9% +3.6% 2,815 ↑ +40.8% +144.8% 2,804 ↑ +40.2% +143.8% -2,525 ↓ -310.4% -465.9%
2024.11 2024/10/11 修正予 57,500 → 0.0% +2.7% 2,000 ↑ +25.0% +73.9% 2,000 ↑ +25.0% +73.9% 1,200 ↑ +50.0% +73.9%
2024.11 2024/07/12 Q2予 57,500 → 0.0% +2.7% 1,600 → 0.0% +39.1% 1,600 → 0.0% +39.1% 800 → 0.0% +15.9%
2024.11 2024/06/26 修正予 57,500 ↑ +2.7% +2.7% 1,600 ↑ +39.1% +39.1% 1,600 ↑ +39.1% +39.1% 800 ↑ +15.9% +15.9%
2024.11 2024/04/12 Q1予 56,000 → 0.0% 0.0% 1,150 → 0.0% 0.0% 1,150 → 0.0% 0.0% 690 → 0.0% 0.0%
2024.11 2024/01/12 当初予 56,000 - - - 1,150 - - - 1,150 - - - 690 - - -
2023.11 2024/01/12 実 51,984 ↑ +0.9% +0.9% 1,127 ↑ +56.5% +56.5% 1,363 ↑ +232.4% +232.4% 1,162 ↑ +11520.0% +11520.0%
2023.11 2023/10/13 Q3予 51,500 → 0.0% 0.0% 720 → 0.0% 0.0% 410 → 0.0% 0.0% 10 → 0.0% 0.0%
2023.11 2023/07/13 Q2予 51,500 → 0.0% 0.0% 720 → 0.0% 0.0% 410 → 0.0% 0.0% 10 → 0.0% 0.0%
2023.11 2023/04/13 Q1予 51,500 → 0.0% 0.0% 720 → 0.0% 0.0% 410 → 0.0% 0.0% 10 → 0.0% 0.0%
2023.11 2023/01/13 当初予 51,500 - - - 720 - - - 410 - - - 10 - - -
2022.11 2023/01/13 実 49,636 ↓ -0.7% -0.7% 819 ↓ -18.1% -51.8% 887 ↓ -11.3% -44.6% 579 ↓ -47.4% -61.4%
2022.11 2022/10/12 Q3予 50,000 → 0.0% 0.0% 1,000 → 0.0% -41.2% 1,000 → 0.0% -37.5% 1,100 → 0.0% -26.7%
2022.11 2022/07/13 Q2予 50,000 → 0.0% 0.0% 1,000 ↓ -41.2% -41.2% 1,000 ↓ -37.5% -37.5% 1,100 ↓ -26.7% -26.7%
2022.11 2022/04/13 Q1予 50,000 → 0.0% 0.0% 1,700 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,500 → 0.0% 0.0%
2022.11 2022/01/13 当初予 50,000 - - - 1,700 - - - 1,600 - - - 1,500 - - -
2021.11 2022/01/13 実 72,322 ↓ -0.9% -0.9% 2,233 ↓ -14.1% -14.1% 2,420 ↓ -10.4% -10.4% 1,736 ↓ -13.2% -13.2%
2021.11 2021/10/13 Q3予 73,000 → 0.0% 0.0% 2,600 → 0.0% 0.0% 2,700 → 0.0% 0.0% 2,000 → 0.0% 0.0%
2021.11 2021/07/09 Q2予 73,000 → 0.0% 0.0% 2,600 → 0.0% 0.0% 2,700 → 0.0% 0.0% 2,000 → 0.0% 0.0%
2021.11 2021/04/09 Q1予 73,000 → 0.0% 0.0% 2,600 → 0.0% 0.0% 2,700 → 0.0% 0.0% 2,000 → 0.0% 0.0%
2021.11 2021/01/13 当初予 73,000 - - - 2,600 - - - 2,700 - - - 2,000 - - -
2020.11 2021/01/13 実 65,341 ↑ +2.1% +2.1% 2,035 ↑ +13.1% -7.5% 1,968 ↑ +6.4% -18.0% 1,983 ↑ +10.2% +16.6%
2020.11 2020/10/09 Q3予 64,000 → 0.0% 0.0% 1,800 ↓ -18.2% -18.2% 1,850 ↓ -22.9% -22.9% 1,800 ↑ +5.9% +5.9%
2020.11 2020/07/10 Q2予 64,000 → 0.0% 0.0% 2,200 → 0.0% 0.0% 2,400 → 0.0% 0.0% 1,700 → 0.0% 0.0%
2020.11 2020/04/10 Q1予 64,000 → 0.0% 0.0% 2,200 → 0.0% 0.0% 2,400 → 0.0% 0.0% 1,700 → 0.0% 0.0%
2020.11 2020/01/10 当初予 64,000 - - - 2,200 - - - 2,400 - - - 1,700 - - -
2019.11 2020/01/10 実 61,647 ↓ -2.1% -2.1% 2,121 ↑ +6.1% +6.1% 2,318 ↑ +15.9% +15.9% 1,533 ↓ -1.1% -1.1%
2019.11 2019/10/11 Q3予 63,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,550 → 0.0% 0.0%
2019.11 2019/07/11 Q2予 63,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,550 → 0.0% 0.0%
2019.11 2019/04/12 Q1予 63,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,550 → 0.0% 0.0%
2019.11 2019/01/11 当初予 63,000 - - - 2,000 - - - 2,000 - - - 1,550 - - -
2018.11 2019/01/11 実 60,083 ↑ +1.8% +1.8% 1,849 ↑ +15.6% +32.1% 2,000 ↑ +16.3% +37.9% 1,414 ↑ +19.8% +48.8%
2018.11 2018/10/12 Q3予 59,000 → 0.0% 0.0% 1,600 → 0.0% +14.3% 1,720 → 0.0% +18.6% 1,180 → 0.0% +24.2%
2018.11 2018/07/12 Q2予 59,000 → 0.0% 0.0% 1,600 → 0.0% +14.3% 1,720 → 0.0% +18.6% 1,180 → 0.0% +24.2%
2018.11 2018/05/25 修正予 59,000 → 0.0% 0.0% 1,600 ↑ +14.3% +14.3% 1,720 ↑ +18.6% +18.6% 1,180 ↑ +24.2% +24.2%
2018.11 2018/04/11 Q1予 59,000 → 0.0% 0.0% - - - - 1,450 → 0.0% 0.0% 950 → 0.0% 0.0%
2018.11 2018/01/12 当初予 59,000 - - - 1,400 - - - 1,450 - - - 950 - - -
2017.11 2018/01/12 実 57,387 ↑ +0.7% -1.1% 1,571 ↑ +4.7% +15.5% 1,778 ↑ +7.8% +27.0% 1,241 ↑ +37.9% +47.7%
2017.11 2017/10/12 Q3予 57,000 → 0.0% -1.7% 1,500 → 0.0% +10.3% 1,650 → 0.0% +17.9% 900 → 0.0% +7.1%
2017.11 2017/07/27 修正予 57,000 ↓ -1.7% -1.7% 1,500 ↑ +10.3% +10.3% 1,650 ↑ +17.9% +17.9% 900 ↑ +7.1% +7.1%
2017.11 2017/07/13 Q2予 58,000 → 0.0% 0.0% 1,360 → 0.0% 0.0% 1,400 → 0.0% 0.0% 840 → 0.0% 0.0%
2017.11 2017/04/12 Q1予 58,000 → 0.0% 0.0% 1,360 → 0.0% 0.0% 1,400 → 0.0% 0.0% 840 → 0.0% 0.0%
2017.11 2017/01/12 当初予 58,000 - - - 1,360 - - - 1,400 - - - 840 - - -
2016.11 2017/01/12 実 55,121 ↓ -1.6% -1.6% 977 ↑ +14.9% +14.9% 1,071 ↑ +19.0% +19.0% -593 ↓ -231.8% -231.8%
2016.11 2016/10/13 Q3予 56,000 → 0.0% 0.0% 850 → 0.0% 0.0% 900 → 0.0% 0.0% 450 → 0.0% 0.0%
2016.11 2016/04/12 Q1予 56,000 → 0.0% 0.0% 850 → 0.0% 0.0% 900 → 0.0% 0.0% 450 → 0.0% 0.0%
2016.11 2016/01/14 当初予 56,000 - - - 850 - - - 900 - - - 450 - - -
2015.11 2016/01/14 実 55,422 → 0.0% +4.6% 559 → 0.0% -37.9% 694 → 0.0% -26.9% -143 → 0.0% -123.8%
2015.11 2016/01/13 修正予 55,422 ↑ +0.8% +4.6% 559 ↓ -12.7% -37.9% 694 ↓ -9.9% -26.9% -143 ↓ - -123.8%
2015.11 2015/10/09 Q3予 55,000 ↑ +3.8% +3.8% 640 ↓ -28.9% -28.9% 770 ↓ -18.9% -18.9% 0 ↓ -100.0% -100.0%
2015.11 2015/07/13 Q2予 53,000 → 0.0% 0.0% 900 → 0.0% 0.0% 950 → 0.0% 0.0% 600 → 0.0% 0.0%
2015.11 2015/04/10 Q1予 53,000 → 0.0% 0.0% 900 → 0.0% 0.0% 950 → 0.0% 0.0% 600 → 0.0% 0.0%
2015.11 2015/01/14 当初予 53,000 - - - 900 - - - 950 - - - 600 - - -
2014.11 2015/01/14 実 54,145 - - - 890 - - - 971 - - - 505 - - -
シェア ツイート
ページトップへ戻る